2022

C ALL FOR P ROPOSALS 2022 HSCI COLLABORATIVE SEED GRANTS AWARD AMOUNT $100,000 per project per year for up to two years DEADLINE FOR APPLICATION Friday, September 16, 2022 ANTICIPATED AWARD DATE Monday, November 14, 2022 The Harvard Stem Cell Institute...

C ALL FOR P ROPOSALS 2022 HSCI JUNIOR FACULTY PROGRAM AWARD AMOUNT $600,000 per year to include three or four subprojects of $150,00-$200,000 for up to three years DEADLINE FOR APPLICATION Friday, August 5, 2022 ANTICIPATED AWARD DATE Tuesday, November 1...

Results suggest a pathway to testing in human clinical trials In a new study, researchers have discovered a method for using engineered donor stem cells to successfully treat glioblastoma in mice. The study revealed the presence of special “death...

New discoveries about the role of alpha-synuclein, a well-known protein marker of Parkinson’s, may provide insights for treatment for the disease One of the hallmarks of Parkinson’s disease (PD) is the accumulation in the brain of a protein known as alpha...

Since their development more than a decade ago, brain organoids — brain-like structures grown in petri dishes from human stem cells — have helped scientists better understand a range of neurological disorders, including schizophrenia, epilepsy, and autism...

HSCI scientists advance Type 1 diabetes therapy by protecting cells from immune attack and stress The stem cell-based approach to treating Type 1 diabetes (T1D) is successfully being tested in the clinic, using a transplant of stem cell-derived beta cells...

Fernando Camargo recognized for pioneering scientific contributions and outstanding leadership Fernando Camargo, Ph.D., has been named as the inaugural Regenerative Biology Endowed Chair by the Boston Children’s Hospital (BCH) Department of Pediatrics, in...

Novel delivery system for tissue-regenerative molecules enables local, sustained release for greater efficacy Alkem Laboratories Limited (Alkem) has signed a license agreement with Harvard University’s Office of Technology Development to develop and...

Combination of 3D bioprinting and stem cell-based tissue engineering could enable new approaches to treating chronic kidney disease A newly launched startup is building on innovations developed over several years at the Wyss Institute for Biologically...